Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.

ACRUX GRANTED FIRST GRANT IN EUROPE, TRIGGERING PAYMENT FROM LILLY

Acrux, the Australia-based pharmaceutical company
with unique technology for delivering drugs through the skin, today announced
that the European Patent Office has granted the key core patent protecting Acrux's
drug delivery technology.
Medical
News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=42788)